1. |
Details of PDMR/person closely associated with them ('PCA') |
a) |
Name |
Mr R G Connor |
b) |
Position/status |
President, Global Manufacturing & Supply |
c) |
Initial notification/ amendment |
Initial notification |
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
GlaxoSmithKline plc |
b) |
LEI |
5493000HZTVUYLO1D793 |
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
a) |
Description of the financial instrument |
Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
b) |
Nature of the transaction |
The sale of 2,250 Ordinary Shares following the exercise of options granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan. |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
£12.9258 |
2,250 |
|
d) |
Aggregated information Aggregated volume Price |
n/a (single transaction) |
e) |
Date of the transaction |
2018-02-12 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |